Eczema (Atopic Dermatitis) Clinical Trials in Columbus
View 30 new treatments for Eczema (Atopic Dermatitis) in Columbus, OH. Every day, Power helps hundreds of Eczema (Atopic Dermatitis) patients connect with leading medical research.Nemolizumab for Eczema
Galderma Clinic, Bexley + 2 more
Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Description
No Placebo Trial
Lebrikizumab for Eczema
Eli Lilly Clinic, Bexley + 3 more
This trial will test the safety and effectiveness of lebrikizumab in people with severe eczema who have already tried another treatment called Dupilumab. Lebrikizumab aims to reduce skin inflammation by blocking a protein that causes it.Show More
No Placebo Trial
Upadacitinib + Topical Corticosteroids for Eczema
AbbVie Clinic, Columbus + 2 more
The objective of this study is to assess the efficacy and safety of upadacitinib combined with topical corticosteroids (TCS) for the treatment of adolescent and adult participants with moderate to severe atopic dermatitis (AD) who are candidates for systemic therapy.Show More
Rocatinlimab for Eczema
Amgen Clinic, Columbus + 1 more
This trial is testing a new medication called rocatinlimab to see if it works well and is safe when used alone. It targets patients who might benefit from a new treatment option.Show More
Amlitelimab for Atopic Dermatitis (COAST 2)
Sanofi Clinic, Bexley + 1 more
This trial tests amlitelimab injections for patients aged 12 and older with moderate to severe atopic dermatitis that isn't controlled by topical treatments. The injections aim to reduce inflammation and symptoms by targeting specific immune pathways.Show More
Abrocitinib for Atopic Dermatitis/Eczema
Pfizer Clinic, Bexley + 3 more
This trial is testing a pill called Abrocitinib to help people aged 12 and older with severe eczema. It aims to see if the pill can reduce inflammation and itching by blocking certain body chemicals. The study includes patients who have already participated in a related study.Show More
Linerixibat for Itching in Cholangitis
GlaxoSmithKline Clinic, Columbus + 1 more
This trial is testing a medication called linerixibat to see if it can help reduce severe itching in people with a liver condition called Primary Biliary Cholangitis (PBC). The study will compare the effects of linerixibat to check its effectiveness and safety.Show More
Rocatinlimab for Atopic Dermatitis
Amgen Clinic, Springfield + 1 more
This trial is testing a medication called rocatinlimab to see if it changes how well people respond to tetanus and meningococcal vaccines by measuring antibody levels.Show More
Rocatinlimab for Atopic Dermatitis
Amgen Clinic, Bexley + 1 more
This trial tests a new drug called rocatinlimab combined with common skin treatments on patients with eczema. The goal is to see if this combination works better than standard treatments alone by calming the immune system to reduce symptoms like redness and itching.Show More
Ruxolitinib Cream for Prurigo Nodularis
Incyte Clinic, Dublin + 1 more
This trial tests the safety and tolerability of a cream for people with Prurigo Nodularis, a condition with itchy skin nodules. The cream works by blocking enzymes that cause inflammation and itching. It has been previously tested for its effects in conditions like atopic dermatitis.Show More
Frequently Asked Questions
How much do eczema clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range. Further, most trials will cover the costs of an Uber to-and-from the clinic. Factors that can affect compensation include the phase of the trial, the length of the trial, the frequency of visits, and the specific condition being studied.
Do I need to be insured to participate in a medical study?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on Cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
How do eczema clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll typical be sorted into one of the treatment groups, and will receive your study drug. For some trials, there is a chance you'll receive a placebo. Across eczema trials in Columbus, 42% of clinical trials have a placebo. Typically you'll be required to check-in with the clinic every month or two. The average trial length in this city for eczema patients is 6 Months.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in getting approval for a specific condition. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. Phase 2 trials are those where the drug has some data showing safety in humans, but where effectiveness has typically only been shown in animals and non-human experiments. Phase 1 trials are the trials where we don't have safety data in humans. As a general rule, phase 3 trials are more promising than phase 2, and phase 2 trials are more promising than phase 1.
Where in Columbus is research being conducted for eczema?
The list does not include any prominent hospitals or neighborhoods in Columbus conducting clinical trials for eczema.
What promising new drugs are being tested?
In Columbus, research for eczema includes treatments like Monoclonal Antibodies and Janus Kinase (JAK) Inhibitors. Specific drugs such as Dupilumab, Tralokinumab, and Upadacitinib are being studied.